Overview

This meeting will highlight key takeaways from the 2024 ASH Symposium, tailored specifically for hematologists, oncologists, primary care physicians, pathologists, fellows in hematology/oncology, oncology nurses, oncology social workers, and other healthcare professionals involved in blood cancer treatment. The program offers a comprehensive review of the latest research developments in hematologic malignancies from the past year, with a focus on their real-world applications in patient care.

Objectives

1. Describe current treatment options and recent advancements in lymphoma, multiple myeloma, leukemia, and myeloid malignancies.
2. Evaluate the development, outcomes, and relevance of clinical research trials, cellular therapies, and transplant options for hematological malignancies.
3. Analyze the emerging roles of immunotherapy, targeted therapies, cellular therapies, and monoclonal antibodies in the treatment of hematological malignancies.
4. Summarize updates in classical hematology, including advancements in the management of bleeding disorders and thrombosis.

Registration

Registration is complimentary; however, we require you to register on the next tab to account for seating and meals. Please click on the tab above to register.

If you have any questions, please contact the Center for Continuing Medical Education at cme@yale.edu.

Accreditation

Accreditation Statement
The Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Designation Statement
Yale School of Medicine approves this live activity for 6.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC POINTS ~ Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn 7.0 Medical Knowledge Only MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) Part II program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure Policy
It is the policy of Yale School of Medicine, Continuing Medical Education (CME), to ensure balance, independence, objectivity, and scientific rigor in all its educational programs.  All individuals involved in the development and presentation of Accredited Continuing Education activities are required to disclose all financial relationship(s) with ineligible companies that has occurred within the past 24 months; and the opportunity to affect the content of CME about the products or services of the commercial interests. This information is disclosed to all activity participants prior to the commencement of the educational activity.

Financial Statement
The Yale School of Medicine and Yale Cancer Center are grateful to their supporters. They are acknowledged in all conference materials. 

Additional Information

This symposium is being held at Anthony's Ocean View, located at 450 Lighthouse Rd, New Haven, CT 06512. Free on-site parking is available.